Reuters -- Pharmaceutical group UCB said the European Commission has lifted restrictions on its Parkinson’s disease drug Neupro, and that its talks with U.S. regulators to once again market the drug there are ongoing.
Reuters -- Pharmaceutical group UCB said the European Commission has lifted restrictions on its Parkinson’s disease drug Neupro, and that its talks with U.S. regulators to once again market the drug there are ongoing.
